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Abstract
Background: During malaria infection the Toll-like receptor 9 (TLR9) is activated through
induction with plasmodium DNA or another malaria motif not yet identified. Although TLR9
activation by malaria parasites is well reported, the implication to the susceptibility to severe
malaria is not clear. The aim of this study was to assess the contribution of genetic variation at TLR9
to severe malaria.
Methods: This study explores the contribution of TLR9 genetic variants to severe malaria using
two approaches. First, an association study of four common single nucleotide polymorphisms was
performed on both family- and population-based studies from Malawian and Gambian populations
(n>6000 individual). Subsequently, it was assessed whether TLR9 expression is affected by cis-acting
variants and if these variants could be mapped. For this work, an allele specific expression (ASE)
assay on a panel of HapMap cell lines was carried out.
Results: No convincing association was found with polymorphisms in TLR9 for malaria severity, in
either Gambian or Malawian populations, using both case-control and family based study designs.
Using an allele specific expression assay it was observed that TLR9 expression is affected by cis-
acting variants, these results were replicated in a second experiment using biological replicates.
Conclusion: By using the largest cohorts analysed to date, as well as a standardized phenotype
definition and study design, no association of TLR9 genetic variants with severe malaria was found.
This analysis considered all common variants in the region, but it is remains possible that there are
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Malaria Journal 2009, 8:44 http://www.malariajournal.com/content/8/1/44rare variants with association signals. This report also shows that TLR9 expression is potentially
modulated through cis-regulatory variants, which may lead to differential inflammatory responses
to infection between individuals.
Background
Exploring the idea that malaria motifs can induce the
innate immune system and initiate an inflammatory
response may lead to a greater understanding of resist-
ance/susceptibility to severe malaria. Several reports have
found that malaria parasites express molecules that are
recognized by Toll-like receptors (TLR), which play a crit-
ical role in the early innate immune response to invading
pathogens. For instance, the malaria pigment haemozoin
has been shown to function as carrier for plasmodium
DNA which stimulates TLR9 and induces inflammation
[1-3]. Activation of TLR9 expressed on dendritic cell has
also been proposed as a mechanism used by malaria par-
asites to trigger regulatory T cells and evade the immune
system [4]. Regulatory T cells were also shown to contrib-
ute to the pathogenesis of severe malaria by suppressing
anti-malarial immunity during Plasmodium berghei ANKA
infection [5]. The correct balance between induction of an
immune response against the malaria parasite and limita-
tion of suppression of host immunity by the parasite
seems essential to control infection.
To assess the clinical relevance of TLR9 polymorphisms
and severe malaria two association studies were con-
ducted in Ghana. While one of the studies did not observe
any clear association with severe malaria[6], another
found TLR9 polymorphisms to be associated with the
clinical manifestation of malaria during pregnancy [7].
Recently, the TLR-9-1486C/T variants was found to be
associated with high parasitaemia in a cohort of patients
with mild malaria from the Amazonian region of Brazil
[8].
This report explores the contribution of TLR9 genetic var-
iants to severe malaria using two approaches. At first, a
large case-control and family-based association studies
was performed in Malawian and Gambian populations
using four common polymorphisms located in the TLR9
gene region. It is also known that distant SNPs can affect
gene expression, and these can only be identified using
functional in vitro assays [9-11]. Therefore, subsequently it
was assessed whether TLR9 expression is affected by cis-
acting variants and whether these variants could be
mapped. Such polymorphism can be further investigated
as candidates for possible association with severe malaria.
Exploiting the fact that TLR9 is a major TLR expressed by
human B cells [12], an allele specific expression (ASE)
assay was performed using HapMap [13] B-lymphoblast-
oid cell lines (LCLs), for which genotypes on hundreds-of-
thousands SNPs exist, permitting the correlation between
expression data and genetic variability [11,14-17] and
thus facilitating the discovery of putative functional poly-
morphisms.
Methods
Study participants
Patient samples were collected as part of ongoing epide-
miological studies of severe malaria at the Royal Victoria
Hospital, Banjul, The Gambia (885 severe malaria cases,
629 controls; 1,044 family trios) and the Queen Elizabeth
Central Hospital, Blantyre, Malawi (712 severe malaria
cases, 416 controls; 248 family trios). The set of nuclear
family trios comprise a severe malaria affected child and
its two (biological) parents, and were assessed as 'true
trios' using the Nuclear software package[18]. All DNA
samples were collected and genotyped following approval
from the relevant research ethics committees and
informed consent from participants.
Phenotypic definition
All cases were children admitted to hospital with evidence
of Plasmodium falciparum on blood film and clinical fea-
tures of severe malaria [19]. Subjects were defined as hav-
ing had 'cerebral malaria' if their Blantyre coma score was
less than or equal to 3 on presentation or early during
admission. A second phenotypic subset of 'severe malarial
anaemia' was defined as those subjects having had a hae-
moglobin density of less than 5 g/dl or a haematocrit less
than 15%. Participants with co-existing severe or chronic
medical conditions (e.g. bacterial pneumonia, kwash-
iorkor) unrelated to a severe malarial infection were
excluded. Controls were cord blood samples obtained
from birth clinics in the same locality as the cases, and
thought to approximate a random sample of the popula-
tion thus, reflecting the true allele frequency. Cerebral
malaria (CM) and severe malarial anaemia (SMA) were
the most common symptoms defining severe malaria.
Sample preparation and genotyping
For the association studies (participants described below)
genomic DNA samples underwent whole genome ampli-
fication through either Primer Extension Pre-amplifica-
tion [20] or Multiple Displacement Amplification [21],
before genotyping on a Sequenom MassArray genotyping
platform. Only the four common SNPs (minor allele fre-
quency (MAF) of at least 5% in the HapMap Yoruba pop-
ulation) in the TLR9 region were genotyped. The majority
of polymorphisms in this region are monomorphic.Page 2 of 8
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als were used, selected from the HapMap collection.
Established lymphoblastoid cell lines (LCLs) from these
individuals were obtained from the Centre d'Etude du
Polymorphisme Humain (CEPH) collection (Coriell
Institute for Medical Research). Cell lines were cultured
has described previously [22].
Expression phenotyping
For expression analysis, total RNA was extracted from cells
lines from each individual using Tri reagent (Sigma). Poly
A+ RNA was isolated from total RNA using the Dynabeads
mRNA Purification Kit (Dynal). Synthesis of First-Strand
cDNA was processed according to the StrataScript™ First-
Strand Synthesis System (Stratagene). The Allelotype plat-
form from Massarray (Sequenom) was utilized for accu-
rate relative quantification of allele specific cDNA and
gDNA transcripts [23]. Primers were designed using the
dedicated software Spectrodesigner (Sequenom). Allele
specific expression quantification was performed accord-
ing to the protocol of Forton et al [15] and Campino et al
[24]. Briefly, for each cDNA and gDNA assays, nine tech-
nical replicates were performed. Biological replicates from
independent cultures were assayed equally. For a given
cDNA or gDNA assay the allelic transcript ratio was calcu-
lated on each of the nine technical replicates from the rel-
ative quantity of the two allele-specific transcripts. The
mean allelic transcript ratio for the whole assay was then
calculated, and normalized to the mean allelic transcript
ratio for the genomic controls. An assay was accepted for
further analysis if the standard error of the mean for the
technical and biological replicates was less than 10%.
HAPMAP haplotypes
Haplotypes were downloaded from the HapMap Phase II
database http://www.hapmap.org. For data analysis,
770,394 markers were used; all monomorphic markers
were excluded from the analysis. Locations of the SNP
markers were based on those of the human reference
sequence http://genome.ucsc.edu of May 2004 (hg 17,
build 35).
Statistical analysis of the case-control and family trio 
association studies
Genotypic deviations from Hardy-Weinberg equilibrium
(HWE) were assessed using a chi-square statistical test.
Case-control association analysis was undertaken by
logistic regression and included the covariates: ethnic
group, gender and the HbS polymorphism. Family-based
association analysis was performed using the transmis-
sion disequilibrium test (TDT) [25], as well as a case-
pseudo-control approach with conditional logistic regres-
sion [26]. The TDT test is robust to the effects of popula-
tion stratification or sub-structure. All analysis was
performed using the R statistical package.
Statistical analysis of allelic expression
For the association analysis, log-transformed ratios of
allele expression values for individuals with the hetero-
zygous genotype at the exonic SNP (rs352140) were used.
To map putative cis-variants a statistical analysis approach
was used, based on the linear regression method (similar
to that developed by Teare et al and Campino et
al)[24,27]. In particular, it was assessed whether there is
evidence of an increasing or decreasing (linear) relation-
ship between the ratio of expressions for the phase-known
heterozygous type 1 (e.g. AG), homozygous types (e.g. AA
and GG), and heterozygous type 2 (e.g. GA) genotypes.
The rationale for the approach is that allelic imbalances
would be observed only in individuals heterozygous for
the cis-acting polymorphism. All analysis was performed
using the R statistical package.
Results and discussion
Association analyses of common TLR9 SNPs and severe 
malaria
To assess the contribution TLR9 polymorphisms to severe
malaria susceptibility/resistance an association analysis
was performed using case-control and trio cohorts from
Malawian (712 cases, 416 controls; 248 family trios) and
The Gambian (885 cases, 629 controls; 1,044 family
trios). Cerebral malaria and severe anaemia were the most
common symptoms defining severe malaria. The majority
of the Gambian (70%) and Malawian (91%) cohorts
comprise cases of cerebral malaria.
Of the four common SNPs in the TLR9 region genotyped
in the Malawian and Gambian cohorts, two were located
in the promoter (-1486 T>C rs187084, -1237 C>T
rs5743836), one was intronic (+1174 A>G rs352139) and
the last was a synonymous SNP located on exon 2 (+2848
G>A rs352140). The observed MAFs observed in the
cohorts are presented in Table 1. There is no evidence of
distortion from Hardy-Weinberg equilibrium (HWE) in
the controls or parents (P > 0.05). There is a high degree
of concordance of the allele frequencies within country
and between the two study designs. The intronic SNP
(+1174-X) is in high linkage disequilibrium (LD) with the
other SNPs, especially with the exonic SNP (+2848-X)
with which it shows a near complete LD (D' = 0.95 in the
Malawian cohort and 0.99 in the Gambian) (Figure 1).
The allele frequencies between the Gambian cases and
controls and among the parents and children from the
trios are very similar (odds ratios (OR) close to 1 in both
studies) (see Table 2). In the Malawian case-control
cohort we observed a weak association between allele
1174-A and severe malaria (OR = 1.21, 95% CI 1.01 –
1.45; p = 0.04). The allele 2848-T showed a marginal pro-
tective effect (OR = 0.82, 95% CI 0.68 – 1.00; p = 0.05).
The + 1174 and +2848 SNPs are in near perfect LD (D'Page 3 of 8
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(1174-A/2848-C, 1174-G/2848-C, 1174-G/2848-T). The
relative risk of disease (95% CI) for haplotypes 1174-G/
2848-C, 1174-G/2848-T and 1174-A/2848-C are 0.95
(95% CI: 1.01–1.33), 0.86 (95% CI 0.80–1.11) and 1.15
(95% CI: 0.73–1.03) with p-values of 0.05, 0.45 and 0.10
respectively. However the effect of these polymorphisms
was not reproducible in the trios, where allele frequencies
between parents and children were comparable, and there
was no evidence of transmission distortion and associa-
tion (Table 2). In the case-control analyses, the allelic tests
do not adjust for any confounding effects, such as popu-
lation substructure, that can affect bias estimates in case-
control study designs. In the genotype analysis of the case-
controls (Table 3), adjusted for the HbS sickle cell poly-
morphism, and also ethnicity in the Gambian study, no
strong signals of genotypic association was found for any
of the four polymorphisms.
The analysis of the Gambia case-control cohorts showed
that there was no evidence of association between severe
malaria and the polymorphisms studied. Similarly for the
Malawi case-controls, there was no strong evidence of
association, but there are some marginal effects consistent
with the haplotype and allelic analyses above. Accounting
for multiple testing would make us less likely to believe
the marginal evidence (P ≈ 0.05) of associations for some
of the polymorphisms and potential haplotype effects.
Mantel-Haenszel pooled estimates of risk for each SNP
across the populations and studies did not lead to signifi-
cant results (p > 0.05). In conclusion, no convincing asso-
ciation was found with polymorphisms at TLR9 for
malaria severity, in either Gambian or Malawian popula-
tions, using both case-control and family based study
designs
Exploring the existence of functional polymorphism 
affecting TLR9 allelic expression
Candidate gene genetic studies are generally restricted to
SNPs covering the gene area as potential regulatory SNPs
localized away from a gene are difficult to identify. There-
fore, as no association was found with SNPs in the TLR9
gene area, there was further exploration into whether
other SNPs which can be far away from the gene could
Linkage disequilibrium patterns between TLR9 polymorphisms in Malawian and Gambian cohortsFigur  1
Linkage disequilibrium patterns between TLR9 polymorphisms in Malawian and Gambian cohorts. Pairwise linkage 
disequilibrium between the four TLR9 polymorphisms was calculated using the normalized disequilibrium coefficient (D').
Table 1: Allelic frequencies of TLR9 polymorphisms
Gambia Malawi
Controls1 Cases Controls1 Cases
Case-control (n) allele 628 883 416 712
TLR9_rs187084 C 0.231 0.227 0.270 0.232
TLR9_rs5743836 C 0.460 0.438 0.407 0.381
TLR9_rs352139 A 0.395 0.413 0.396 0.444
TLR9_rs352140_exonic T 0.244 0.249 0.302 0.263
Trios (n) 2086 1043 376 188
TLR9_rs187084 C 0.237 0.236 0.269 0.266
TLR9_rs5743836 C 0.481 0.478 0.406 0.399
TLR9_rs352139 A 0.435 0.418 0.378 0.391
TLR9_rs352140_exonic T 0.248 0.249 0.323 0.321
1 For the trios' cohort the parents were used as controls.Page 4 of 8
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sion.
Numerous studies have recently contributed to the identi-
fication of putative regulatory variants by correlating total
gene expression or allele specific expression data with
genetic variability[11,16,17,28] Using a similar approach,
in this report an allele specific expression (ASE) assay was
performed on a panel of HapMap B-lymphoblastoid cell
lines (LCL) for which genotyped data is available and
facilitates the mapping of functional polymorphisms.
These cell lines have been widely used to map cis/trans reg-
ulatory regions and recent publications have shown high
consistence between cis-regulation results obtained using
HapMap cell lines and primary tissue[29].
The strength of the ASE assay is the possibility to compare
the relative expression of the two alleles in heterozygous
individuals within the same cellular sample. Therefore,
both alleles will be exposed to the same environmental,
technical and genetic factors (e.g. trans-acting effect). If the
expression of the alleles is not equal (allelic imbalance), it
suggests that the expression of the gene is under cis-regu-
lation.
Cell lines from individuals of northern and western
Europe origin (CEU) and from Yoruba of Ibadan, Nigeria
(YRI) were selected from the HapMap collection [13] and
were genotyped for a exonic synonymous SNP present on
the TLR9 gene. Since this SNP is located within a part of
the gene that is transcribed, it is possible to discriminate
between allelic transcripts in heterozygous individuals.
Twenty-one unrelated CEU and nineteen YRI individuals
were found to be heterozygous for this SNP and were used
for the ASE analysis. For these individuals, their genomic
DNA was used to obtain the reference equi-molar ratio
between the two alleles (allele1 and allele2), and this was
Table 2: Severe malaria and TLR9 allelic-based association analysis
The Gambia Malawi
Case-control alleles OR1 95% CI2 p-value3 OR 95% CI p-value3
rs187084 C vs T 0.98 0.82 1.16 0.81 0.82 0.66 1.01 0.06
rs5743836 C vs T 0.92 0.78 1.07 0.26 0.90 0.75 1.08 0.26
rs352139 A vs G 1.08 0.93 1.25 0.33 1.21 1.01 1.45 0.04
rs352140 T vs C 1.03 0.87 1.21 0.77 0.82 0.68 1.00 0.05
Trios
rs187084 C vs T 0.95 0.82 1.11 0.55 0.91 0.66 1.26 0.56
rs5743836 C vs T 0.95 0.78 1.16 0.62 0.82 0.59 1.16 0.26
rs352139 A vs G 0.92 0.82 1.05 0.22 1.07 0.77 1.49 0.67
rs352140 T vs C 1.00 0.87 1.16 0.97 0.99 0.72 1.36 0.94
1OR = odds ratio,
2 CI = confidence interval
3 for the trios these are TDT p-values
Table 3: Severe malaria and TLR9 genotype-based association analysis
The Gambia1 Malawi2
Case-control genotypes OR 95% CI p-value OR 95% CI p-value
rs187084 CT vs TT 0.96 0.75 1.23 0.79 0.82 0.62 1.09 0.17
CC v TT 0.98 0.57 1.70 0.97 0.60 0.35 1.02 0.06
rs5743836 CT vs TT 0.98 0.74 1.30 0.90 1.01 0.75 1.34 0.95
CC vs TT 0.81 0.56 1.15 0.25 0.63 0.42 0.97 0.04
rs352139 AG vs GG 1.01 0.77 1.30 0.97 1.22 0.91 1.63 0.17
AA vs GG 1.22 0.85 1.74 0.27 1.43 0.98 2.07 0.06
rs352140 TC vs CC 0.97 0.76 1.24 0.84 0.77 0.59 1.01 0.06
TT vs CC 1.36 0.82 2.26 0.22 0.78 0.49 1.25 0.31
1Adjusted for HbS and ethnicity
2 Adjusted for HbSPage 5 of 8
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expression imbalance (AEI) was determined if independ-
ent replicate assays in the RNA samples showed differen-
tial allele expression ratios that deviated from the
genomic DNA. If there is no allelic imbalance then the
ratio of the two alleles (allele1/allele2) will be equal to
one. A ratio greater than one indicates an over-expression
of allele1, while a ratio smaller than one indicates an over-
expression of allele2.
Of the 21 CEU individuals, 17 (84%) showed no or low
magnitude allelic variation (both alleles expressed nearly
equally) (Figure 2). However, for three individuals, the
allelic transcript A was clearly over-expressed (ratios
between 1.3 and 1.87) and for one individual this allelic
transcript was clearly under-expressed (average ratio of
0.5). As for the CEU population, almost all the YRI sam-
ples (80%) showed low magnitude allelic variation (Fig-
ure 2). However, three individuals showed over-
expression (ratios between 1.2 and 1.67) of allele A, and
one individual relatively under-expression of the same
allele (average ratio of 0.7). Biological replicates from
independent cultures yielded convergent results (Pearson
correlation coefficient r = 0.84). Since the overall experi-
mental variability was very low, being little influenced by
variations in cell culture or other experimental tech-
niques, these results strongly suggest that the allelic
imbalances observed in the six individuals studied here
represent a true biological phenomenon. As the allelic
imbalance data observed was bidirectional, i.e. showing
over-expression of different alleles among the cell lines,
the cis-acting variant is likely to be in low LD with the tran-
script SNP [15,27].
To map potential cis-acting variants that might be respon-
sible for the allelic imbalances observed in the TLR9 gene,
the allele ratio data is correlated with haplotypes (~400 kb
surrounding each side of the TLR9 gene) of the HapMap
individuals considered using a linear regression approach
(described in materials and methods) [15,24]. CEU and
YRI sample sets were analysed independently. No signifi-
cant associations were found between allelic imbalances
and the 278 SNPs surrounding TLR9 gene including the
promoter and intronic SNPs analysed (Figure 3). The fact
that it was not possible to map any putative cis-variants
might be because the allelic imbalances observed were
caused by variants still not represented by HapMap data at
the current level of SNP ascertainment or due to the
reduced statistical power resulting from the small sample
size used (21 CEU and 19 YRI).
Overall, while no functional polymorphism were mapped
using the current HapMap genotyping data, this data
shows that TLR9 expression is potentially modulated
through cis-regulatory variants.
Allele specific differences in TLR9 expressionFigure 2
Allele specific differences in TLR9 expression. Log2 
allelic expression ratio between the A allele and the G allele 
in individuals heterozygous for the rs352140. Represented 
are the results for the 21 CEU and 19 YRI individuals. The 
mean allelic transcript ratio for each cDNA sample was nor-
malised to the mean allelic transcript ratio of the respective 
gDNA control. The horizontal dashed lines indicate the A/G 
allele ratio of 1.
Mapping putative cis-variants acting on TLR9 gene expressionFigure 3
Mapping putative cis-variants acting on TLR9 gene 
expression. Allele transcript ratio mapping for 278 SNP 
across ~400 kb each side of the TLR9 gene. No association 
was found with any SNP surrounding the TLR9 gene. Y-axis 
represents the -log10 p-value and the x-axis the location in 
the chromosome. The horizontal dashed line indicates a 
nominal p-value of 0.01. The horizontal dashed and pointed 
line indicates the region-wide significance threshold of 1% 
calculated by performing 1000 permutations. The vertical 
dashed line indicates the position of the TLR9 transcribed 
SNP (rs352140). Each bullet represents a tested SNP. This 
data was obtained using the CEU data set. Similar results 
were obtained for the YRI.Page 6 of 8
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To determine if genetic variation in the TLR9 gene influ-
ences disease outcome in malaria, a genetic association
study was conducted to investigate the possible effect of
TLR9 polymorphisms on severe malaria in two African
populations. This study uses a standardized phenotype
definition and study design, is the largest of its kind to
date for TLR9, and includes both case-control and family-
based data. No association was found with TLR9 poly-
morphism and severe manifestation of malaria in the
Gambian cohorts and only a weak effect was observed in
the Malawi case-control study. In the latter, it was not pos-
sible to adjust the potentially confounding effect of eth-
nicity, and possible population structure. When the more
robust TDT analysis was applied to the Malawian trios, no
association was observed. This analysis considered all
common variants in the TLR9 region, but it remains pos-
sible that there are rare variants with association signals.
It is also possible that there exist TLR9 regulatory variants
that contribute to severe malaria resistance/susceptibility
that have not been mapped. It is known that regulatory
polymorphisms which control gene expression can be
localized hundreds of kb from the gene they influ-
ence[10,15]. Selection of candidate SNPs for association
analysis close to the gene of interest is therefore likely to
miss distant functional polymorphisms. One approach
that will enrich potential functional polymorphism in
association analysis is to use expression studies to identify
SNPs that modulate gene expression. In an attempt to find
putative cis-variants affecting TLR9 expression, an allele-
specific expression assays was carried out in LCL from
both CEU and YRI HapMap individuals. Interestingly,
allelic expression imbalances were observed in both sam-
ple sets, which is reproducible in the same individuals,
indicating strongly the existence of cis-regulation. This
observation indicates clearly that different individuals
might differ in the expression of TLR9, which can lead to
different responses to the stimulus induced by malaria
motifs or other pathogens. The identification of these
functional genetic variants will be crucial to attest any
involvement of TLR9 in severe malaria. The finding that
TLR9 expression is under cis-regulation will strongly pave
the path for further studies of infectious diseases, includ-
ing the consequences of differential TLR9 activation.
Although evidence of cis-regulation of TLR9 expression
was found, it was not possible to identify polymorphisms
that correlated with the observed distortion. This is likely
to be due to the incomplete polymorphism coverage of
the HapMap and by the small sample sizes of the current
available LCL. Increasing the number of available cell
lines with abundant genotyping data or the application of
new re-sequencing technologies to discover new and rare
polymorphism will greatly facilitate the identification of
functional variants. This work illustrates the need to
upscale approaches and resources in expression analysis
in the search for disease associated variants.
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